×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [5]
山东大学 [2]
内容类型
期刊论文 [7]
发表日期
2020 [1]
2019 [1]
2018 [1]
2017 [1]
2013 [1]
2012 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共7条,第1-7条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
2-Oxo-3,4-dihydropyrimido[4,5-d] pyrimidines as new reversible inhibitors of EGFR C797S (Cys797 to Ser797) mutant
期刊论文
CHINESE CHEMICAL LETTERS, 2020, 卷号: 31, 期号: 5, 页码: 1281-1287
作者:
Hu, Xianglong
;
Xun, Qiuju
;
Zhang, Tao
;
Zhu, Su-Jie
;
Li, Qian
收藏
  |  
浏览/下载:48/0
  |  
提交时间:2020/07/01
EGFR(C797S) mutant
SARs
2-Oxo-3,4-dihydropyrimido[4,5-d] pyrimidine
Clinical resistance
Fourth-generation inhibitors
Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR(L858R/T790M/C797S)
期刊论文
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 卷号: 10, 期号: 6, 页码: 869-873
作者:
Li, Qiannan
;
Zhang, Tao
;
Li, Shiliang
;
Tong, Linjiang
;
Li, Junyu
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2020/07/01
EGFR
mutant
inhibitor
C797S
Revisiting the molecular mechanism of acquired resistance to reversible tyrosine kinase inhibitors caused by EGFR gatekeeper T790M mutation in non-small-cell lung cancer
期刊论文
MEDICINAL CHEMISTRY RESEARCH, 2018, 卷号: 27, 期号: 9, 页码: 2160-2170
作者:
Zhao, Yan
;
Jiao, Yingjie
;
Sun, Fengzhe
;
Liu, Xudong
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/11
Epidermal growth factor receptor
Gatekeeper T790M mutation
Tyrosine
kinase inhibitor
Acquired resistance
Non-small-cell lung cancer
Structure-based design and synthesis of 2,4-diaminopyrimidines as EGFR L858R/T790M selective inhibitors for NSCLC
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 140, 页码: 510-527
作者:
Chen, Lingfeng
;
Fu, Weitao
;
Feng, Chen
;
Qu, Rong
;
Tong, Linjiang
收藏
  |  
浏览/下载:57/0
  |  
提交时间:2019/01/08
Epidermal growth factor receptor
Tyrosine kinase inhibitors
Non-small cell lung cancer
T790M
Mutant-selective
Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor
期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 卷号: 21, 期号: 24, 页码: 7988-7998
作者:
Zhang, Xu
;
Peng, Ting
;
Ji, Xun
;
Li, Jian
;
Tong, Linjiang
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2019/01/08
EGFR inhibitor
EGFR T790M/L858R
Binding mode
Irreversible EGFR inhibitor
Recent developments of small molecule EGFR inhibitors based on the quinazoline core scaffolds
期刊论文
Anti-cancer agents in medicinal chemistry, 2012, 卷号: 12, 期号: 4, 页码: 391-406
作者:
Liu,Y.-J.
;
Zhang,C.-M.
;
Liu,Z.-P.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/23
Anilinoquinazolines
Anti-tumor
ATP-binding
Cytotoxicity
Dual inhibitors
EGFR
EGFR inhibitors
HER2
Irreversible EGFR inhibitors
Ligands
Nonanilininoquinazolines
Reversible EGFR inhibitors
SAR
AST1306, A Novel Irreversible Inhibitor of the Epidermal Growth Factor Receptor 1 and 2, Exhibits Antitumor Activity Both In Vitro and In Vivo
期刊论文
PLOS ONE, 2011, 卷号: 6, 期号: 7
作者:
Xie, Hua
;
Lin, Liping
;
Tong, Linjiang
;
Jiang, Yong
;
Zheng, Mingyue
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2019/01/08
©版权所有 ©2017 CSpace - Powered by
CSpace